Please Wait.....
Report
Livestock Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
Market Report I 2025-04-30 I 160 Pages I Global Market Insights
The Global Livestock Vaccines Market was valued at USD 6.4 billion in 2024 and is estimated to grow at a CAGR of 7.1% to reach USD 12.6 billion by 2034, driven by increased awareness of animal health, the expansion of industrial farming, and advancements in vaccine technology. This rising trend is largely attributed to the heightened focus on disease prevention among farmers and a growing understanding of the economic advantages linked to immunization. As livestock farming becomes more industrialized, the need for comprehensive disease management strategies grows stronger. Technological innovation has further enabled the development of highly effective vaccines, strengthening animal health outcomes and improving productivity across farms. The emergence of frequent disease outbreaks globally has led to increased urgency around preventive measures, especially for poultry, which remains a highly vulnerable category. Global food security is increasingly reliant on livestock productivity, making animal health a critical aspect of agricultural sustainability. Moreover, the reduction in losses due to illness and mortality directly supports the economic viability of farming operations, especially in high-density production settings. The market continues to benefit from favorable government policies, industry collaborations, and increased investments in animal healthcare infrastructure.
Livestock animals such as cattle, swine, poultry, aquaculture species, and sheep and goats are central to the agricultural economy, serving various purposes including food production, fiber, and labor. Vaccination is widely recognized as an essential tool for safeguarding animal health and reducing the economic impact of infectious diseases. In 2024, the poultry segment held the largest market share, generating USD 2.4 billion in revenue, and is projected to reach USD 4.5 billion by 2034, growing at a CAGR of 6.5%. Poultry remains a global dietary staple, largely due to its lower production costs and faster turnover compared to other livestock. Increased demand for poultry products, particularly in rapidly developing regions, has accelerated the adoption of mass vaccination practices. The industry faces ongoing threats from viral and bacterial outbreaks, which have emphasized the importance of robust vaccination programs.
Among vaccine types, attenuated live vaccines dominate the market, holding a 45.9% share in 2024. This segment is expected to maintain its leading position through 2034 with a CAGR of 6.7%. These vaccines are highly effective because they mimic natural infections, providing strong and long-lasting immunity with fewer doses. Their use is common in addressing serious livestock diseases, making them a preferred solution for large-scale animal health management. These vaccines are also known for providing quicker immune responses, an essential factor in intensive farming setups where disease can spread rapidly.
Regarding administration routes, the oral segment is gaining significant traction due to its convenience and effectiveness in large-scale operations. Valued at USD 7.1 billion by 2034, this segment is projected to grow at a CAGR of 6.8%. Oral vaccines offer a stress-free way to immunize animals, especially in poultry, swine, and cattle sectors. Their ability to be administered through feed or water reduces handling, thereby minimizing injury risks and ensuring higher compliance across herds. Technological progress in vaccine formulation has improved the stability and efficiency of oral vaccines, making them increasingly suitable for widespread use.
In terms of applications, viral infection vaccines hold a substantial share of the market, anticipated to reach USD 6.8 billion by 2034, with a CAGR of 7.2%. Recurring viral outbreaks continue to pose major challenges to the livestock industry, both in terms of animal health and economic impact. These diseases significantly reduce production yields, compelling farmers to adopt effective preventive solutions. The ongoing investment in research and development by vaccine manufacturers is expected to drive innovation in this segment, improving the efficacy and accessibility of viral vaccines.
When it comes to distribution, veterinary hospital pharmacies accounted for the largest revenue share of USD 3.3 billion in 2024 and are forecasted to hit USD 6.4 billion by 2034, growing at a CAGR of 6.9%. These facilities are preferred for their comprehensive care offerings, including diagnostics, consultations, and immediate vaccine administration. The expansion of veterinary care networks, especially in emerging markets, is contributing to better access to animal healthcare. The structured delivery system in veterinary hospitals ensures timely vaccination, reducing missed opportunities and increasing overall effectiveness.
The United States leads the North American livestock vaccines market, achieving a valuation of USD 2.4 billion in 2024. This leadership is supported by an advanced animal healthcare framework, high veterinary expenditure, and consistent government support for preventive livestock care. Disease prevalence continues to drive demand for vaccination, pushing the market forward.
Key players such as Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, and Ceva collectively hold around 45% of the global market. Their dominance is attributed to broad product lines, strong global distribution networks, and strategic investments in next-generation vaccine development. The livestock vaccines industry remains moderately consolidated, with these leaders setting the pace for innovation, efficiency, and sustainability in animal health solutions.
Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of livestock diseases
3.2.1.2 Growing awareness among farmers about the benefits of vaccination.
3.2.1.3 Government initiatives and policies supporting animal health and food security.
3.2.1.4 Technological advancements leading to the development of more effective vaccines
3.2.2 Industry pitfalls and challenges
3.2.2.1 High costs associated with vaccine development and distribution
3.2.2.2 Regulatory hurdles that can delay product approvals and market entry.
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Trump administration tariffs
3.5.1 Impact on trade
3.5.1.1 Trade volume disruptions
3.5.1.2 Retaliatory measures
3.5.2 Impact on the industry
3.5.2.1 Supply-side impact (raw materials)
3.5.2.1.1 Price volatility in key materials
3.5.2.1.2 Supply chain restructuring
3.5.2.1.3 Production cost implications
3.5.2.2 Demand-side impact (selling price)
3.5.2.2.1 Price transmission to end markets
3.5.2.2.2 Market share dynamics
3.5.2.2.3 Consumer response patterns
3.5.3 Key companies impacted
3.5.4 Strategic industry responses
3.5.4.1 Supply chain reconfiguration
3.5.4.2 Pricing and product strategies
3.5.4.3 Policy engagement
3.5.5 Outlook and future considerations
3.6 Pipeline analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)
5.1 Key trends
5.2 Poultry
5.3 Cattle
5.4 Swine
5.5 Aquaculture
5.6 Sheep and goats
Chapter 6 Market Estimates and Forecast, By Vaccine Type, 2021 - 2034 ($ Mn)
6.1 Key trends
6.2 Attenuated live vaccine
6.3 Conjugate vaccine
6.4 Inactivated vaccine
6.5 Recombinant vaccine
6.6 Other vaccine types
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 - 2034 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Parentral
7.4 Other routes of administration
Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)
8.1 Key trends
8.2 Bacterial infections
8.3 Viral infections
8.4 Parasitic infections
8.5 Other applications
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)
9.1 Key trends
9.2 Veterinary hospital pharmacies
9.3 Retail pharmacies
9.4 E-commerce
Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
Chapter 11 Company Profiles
11.1 Biogenesis Bago
11.2 Bioveta
11.3 Boehringer Ingelheim
11.4 Ceva
11.5 Elanco
11.6 HIPRA
11.7 Indian Immunologicals
11.8 Merck Animal Health
11.9 Neogen
11.10 Phibro Animal Health
11.11 SAN VET
11.12 Vaxxinova
11.13 Venkys
11.14 Virbac
11.15 Zoetis
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security